1994
DOI: 10.1097/00007890-199408000-00014
|View full text |Cite
|
Sign up to set email alerts
|

EVIDENCE THAT INTRAVENOUSLY ADMINISTERED Α-Galactosyl CARBOHYDRATES REDUCE BABOON SERUM CYTOTOXICITY TO PIG KIDNEY CELLS (PK15) AND TRANSPLANTED PIG HEARTS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
64
0

Year Published

1996
1996
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 125 publications
(64 citation statements)
references
References 0 publications
0
64
0
Order By: Relevance
“…It is possible that Gal-negative cells may be lysed by two different mechanisms: binding of xenoreactive antibodies to non-Gal epitopes (causing complement activation) or activation of the alternative complement pathway. Several reports have suggested that human preformed anti-Gal antibodies are the major, if not exclusive, xenoreactive antibodies responsible for hyperacute rejection (11,(30)(31)(32) and that adsorption of these antibodies may reduce the serum's cytotoxicity (33,34). However, it has also been shown that human anti-Gal antibodies are capable of recognizing alternative ligands, which still remain uncharacterized (35).…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that Gal-negative cells may be lysed by two different mechanisms: binding of xenoreactive antibodies to non-Gal epitopes (causing complement activation) or activation of the alternative complement pathway. Several reports have suggested that human preformed anti-Gal antibodies are the major, if not exclusive, xenoreactive antibodies responsible for hyperacute rejection (11,(30)(31)(32) and that adsorption of these antibodies may reduce the serum's cytotoxicity (33,34). However, it has also been shown that human anti-Gal antibodies are capable of recognizing alternative ligands, which still remain uncharacterized (35).…”
Section: Discussionmentioning
confidence: 99%
“…Specific treatments for the neutralization of anti-αGal antibodies have involved the continuous or intermittent infusion or injection in vivo of soluble sugars, αGal oligosaccharides or specific polymers expressing the αGal epitope. Infusion of high concentrations of melibiose and/or arabinogalactan in baboons was partially effective in eliminating the cytotoxicity of baboon sera on porcine kidney cells although such preparations proved toxic [158]. Intravenous infusion of αGal oligosaccharides showed less toxicity, allowing neutralization of anti-αGal activity and delay of HAR [164,165].…”
Section: Blocking Of Circulating Xenoreactive Antibodiesmentioning
confidence: 99%
“…Both protein A and protein G, which bind the Fc portion of antibodies, and anti-Ig affinity columns, allowed removal of immunoglobulins irrespective of their specificity [155][156][157]. Apheresis with plasma perfusion through specific antibody sorbents such as α-Galactosyl carbohydrates [158] and natural or synthetic αGal oligosaccharides [159][160][161] allowed efficient anti-αGal antibody removal. Finally, antiidiotypic antibodies directed against specific idiotypes of anti-αGal antibodies, were shown to be able to remove up to 90% of cytotoxic anti-pig antibodies from the circulation of treated baboons [157,162].…”
Section: Removal Of Xenoreactive Antibodiesmentioning
confidence: 99%
“…The Ab bound to the intravenously infused Gal-conjugate, and was excreted with it through the liver and kidneys. Initial exploration used melibiose, a relatively non-specific oligosaccharide, 35 but this was not suitable for prolonged administration. More specific glycoconjugates were developed, some of which were administered intermittently and others by continuous intravenous (IV) infusion.…”
Section: Phase V: Continuous "Depletion" or "Neutralization" Of Anti-mentioning
confidence: 99%